A Clinical Study to Evaluate GK01 Cell Injection in Combination With PD-1 Monoclonal Antibody for Advanced Solid Tumors
Clinical trial NCT07407985 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07407985
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-04
- Primary completion
- 2027-12-03
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.